Novonesis (novozymes)-ADRNVZMY
13F holders, Q4 2025 (December 31)11holders +2
2new positions
1sold out
$63.79avg. 13F price*
At the end of Q4 2025, 11 institutions reported holding Novonesis (novozymes)-ADR (NVZMY) in their 13F filings, up 2 from Q3 2025. 2 opened new positions and 1 sold out. The largest holders were Rhumbline Advisers ($637K), Sterling Capital Management LLC ($343K) and S&co Inc. ($288K).
- Company
- Novonesis (novozymes)-ADR
- Filed as
- NOVOZYMES A/S-UNSPONS ADR (Q4 2025)
- CUSIP
- 670108109
- Latest filing quarter
- Q2 2026
History
Number of 13F holders
Total Exit/New Position Q3 2025 → Q4 2025
| Institutions | Total Value | |
|---|---|---|
| New Positions | 2 | $11K |
| Exits | 1 | $283K |
All 13F filers, Q3 2025 → Q4 2025: 223 shares bought and 6,086 shares sold, net −5,863 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 11 holders
| Rhumbline Advisers | 0.00% | Reduce -2.1% | 10,013 | $637K |
| Sterling Capital Management LLC | 0.01% | Reduce -16.8% | 5,346 | $343K |
| S&co Inc. | 0.02% | No change | 4,500 | $288K |
| GAMMA Investing LLC | 0.01% | Reduce -5.3% | 2,275 | $145K |
| PNC Financial Services Group, Inc. | 0.00% | Reduce -1.5% | 1,553 | $99K |
| Salomon & Ludwin, LLC | 0.00% | Add +27.4% | 237 | $15K |
| Ancora Advisors LLC | 0.00% | New | 157 | $10K |
| Copeland Capital Management, LLC | 0.00% | No change | 49 | $3K |
| Signature Equity Partners, LLC | 0.00% | — | 32 | $2K |
| IMA Advisory Services, Inc. | 0.00% | New | 15 | $954 |
| Ameriflex Group, Inc. | 0.00% | Reduce -50.0% | 14 | $891 |
"% of holder's portfolio" is NVZMY's weight in each manager's 13F, not the share of Novonesis (novozymes)-ADR the manager owns.